Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. - Wikidata - awgldk - TriplyDB

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

http://www.wikidata.org/entity/Q38689374

about

Ten-Year Review of Perioperative Complications After Transurethral Resection of Bladder Tumors: Analysis of Monopolar and Plasmakinetic Bipolar Cases.Bladder Cancer Recovery Pathways: A Systematic Review.Systematic Review and Meta-Analysis on the Efficacy of Chemotherapy with Transurethral Resection of Bladder Tumors as Definitive Therapy for Muscle Invasive Bladder Cancer.Intravesical radiofrequency induced hyperthermia enhances mitomycin C accumulation in tumour tissue.Disparities in the Use of Continent Urinary Diversions after Radical Cystectomy for Bladder Cancer.Challenges facing regionalization of radical cystectomy.Putting guidelines into practice: has the era of perioperative chemotherapy arrived?Circulating Tumour DNA in Muscle-Invasive Bladder Cancer Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients A Festschrift in Honor of Edward M. Messing, MD, FACS Intravesical Radiofrequency-Induced Chemohyperthermia for Carcinoma of the Urinary Bladder: A Retrospective Multicentre Study Biomarkers for Predicting Clinical Outcomes of Chemoradiation-Based Bladder Preservation Therapy for Muscle-Invasive Bladder Cancer Upper Tract Imaging in Patients with Initial or Terminal Hematuria Suggestive of Bleeding from the Lower Urinary Tract: How Often is the Upper Urinary Tract Responsible for the Hematuria?

P2860

Q39338341-5E10745C-D32D-47C5-B636-D59AAF8C2EF2 Q45934647-8407782B-1A40-4FE5-8B2D-4E223ED54700 Q47134723-EEC1C204-0F18-4504-865A-F42A1FFD99CB Q49483341-198ED819-152C-453F-BDA9-B1E352BE714E Q49763935-593F1987-B05B-4B36-84D5-67B37BF4A0F8 Q54960847-D3A46734-6DC7-4B1F-8EC0-A5728D15082B Q55261714-E9A8064F-7768-47A1-A76B-5D4C4428B40B Q57166936-90770197-AC77-41A2-9CF5-AB0ED0A7B75E Q57640095-85146772-4DCF-477F-A5DE-0C1A97823285 Q57825314-711DFCF1-857C-4D6C-8E51-21B64700C441 Q58691149-43D34E0D-99A7-4E34-A485-50222807D86B Q58705075-ADE9BB67-F4FB-413C-B216-DC677763B013 Q58736803-65893707-EA28-4288-A912-A2E79DF13562 Q58775509-AF995BFE-5306-425C-8F4A-7EC10481A2FF

P2860

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

http://www.wikidata.org/entity/Q38689374

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

@en

type

label

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

@en

prefLabel

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

@en

P1433

Q38689374-5111C4D8-40BA-41C9-A581-8672314F7228

P1476

Q38689374-2D8B2DA0-01B7-4448-BBEB-0FA0C2E70690

P2093

Q38689374-15705D77-2845-4A41-AC33-7C97788D645B

Q38689374-222965B5-4894-4485-92F1-D42831D85363

Q38689374-3096A36A-BD9F-46A3-8D36-37CDDCF0908E

Q38689374-3912B05D-9EB8-40C9-B4B4-2D55A21A07C4

Q38689374-3CB8FF17-FFFF-4DB2-81C2-BAC3AEE489B9

Q38689374-77468FE9-FE7C-4414-81F1-233D53D828B1

Q38689374-8917EEB5-973E-4261-B347-5E0C27DA68A6

Q38689374-94E1C044-A160-4CB1-A3A4-772795C81ECD

Q38689374-994AC8DB-DA59-444B-AC64-99E0A02FF37D

Q38689374-ADBBDB3D-F163-430E-8E75-CE6B0B6D26E5

P2860

Q38689374-08897051-2CF1-41F7-8BC0-57CF37F7E156

Q38689374-24EFCFA8-4876-40F3-97CB-B0620A4B3E06

Q38689374-29748E10-8888-4FF6-917B-67ECD4005735

Q38689374-2A879ABC-579C-4AC1-9A81-976D3276CD13

Q38689374-367E60D7-3F1E-4B04-8A85-B24D496C6E5E

Q38689374-3A2154EC-8C80-4FD7-9F47-E0333BD8B55B

Q38689374-4091C14C-3348-4890-9924-3D5EC442D192

Q38689374-412F4045-7BFC-4004-9F4D-445C65943CCB

Q38689374-4652C405-EFCD-40A8-BDA2-3273E25FB727

Q38689374-4C7A0066-F4AA-44F8-9434-714B1CC852E6

P304

Q38689374-7403E8EA-79DD-4EBE-A987-339F36CEAFC2

P31

Q38689374-F8B33C32-66BB-459F-B8BC-66C2C1C2E4CA

P356

Q38689374-E22BB014-01C5-4EB2-BEC6-C6AE394511FA

P407

Q38689374-5A47ACB2-E1CF-4126-9DA1-63B7A03A946B

P433

Q38689374-7F5A25B3-E48E-4A52-854D-C033ECB2622A

P478

Q38689374-B691F3E3-CCED-49C1-A4DF-B1F6B8E35BE2

P50

Q38689374-4A9B5A47-F3EE-4D14-A164-79748632543A

P577

Q38689374-079F4C94-9026-486F-A63A-7C1452E3CAD4

P698

Q38689374-6E976155-1864-458F-8145-C81D2396A7C0

P932

Q38689374-FF53ABC7-05A9-4AE2-9615-A2080D63E1DE

P356

J.JURO.2017.04.086

P1433

The Journal of Urology

P1476

Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.

@en

P2093

Anthony L Zietman

http://www.w3.org/2001/XMLSchema#string

Ashish M Kamat

http://www.w3.org/2001/XMLSchema#string

Bernard H Bochner

http://www.w3.org/2001/XMLSchema#string

Diane Z Quale

http://www.w3.org/2001/XMLSchema#string

Jeff M Michalski

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Holzbeierlein

http://www.w3.org/2001/XMLSchema#string

Jonathan E Rosenberg

http://www.w3.org/2001/XMLSchema#string

Joshua J Meeks

http://www.w3.org/2001/XMLSchema#string

Robert Dreicer

http://www.w3.org/2001/XMLSchema#string

Roger Chou

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant chemotherapy for invasive bladder cancer (individual patient data)

Complications of Radical Cystectomy and Orthotopic Reconstruction

A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci

Refining patient selection for neoadjuvant chemotherapy before radical cystectomy

Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base.

Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.

Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: a review of SEER data, 2004-2010

Metabolic changes after urinary diversion

Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.

Association between smoking and risk of bladder cancer among men and women.

P304

552-559

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2017.04.086

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

198

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28456635

http://www.w3.org/2001/XMLSchema#string

P932

5626446

http://www.w3.org/2001/XMLSchema#string